Startup InPress Reports First Clinical Data For Postpartum Hemorrhage Device
This article was originally published in The Gray Sheet
Executive Summary
Data from 10 patients supports quick action to stop hemorrhages, the leading cause of perinatal maternal death. InPress Technologies hopes to launch an FDA trial later this year.